Loading…

Connection between APOE4 and tau is mediated via amyloid‐beta and Alzheimer’s co‐pathologies in human autopsy brains

Background Alzheimer’s disease (AD) brains commonly exhibit various co‐morbid pathologies, with cerebral amyloid angiopathy (CAA) being the most prevalent, affecting 70‐90% of patients. CAA can be restricted to medium and large vessels or extend to capillaries. Additionally, AD patients often show p...

Full description

Saved in:
Bibliographic Details
Published in:Alzheimer's & dementia 2024-12, Vol.20 (S1), p.n/a
Main Authors: Gawor, Klara, Verrept, Sam, Laureyssen, Celeste, Tomé, Sandra O., Vandenberghe, Rik, Vandenbulcke, Mathieu, Van Damme, Philip, von Arnim, Christina, Otto, Markus, Ghebremedhin, Estifanos, Ronisz, Alicja, Ospitalieri, Simona, Blaschko, Matthew, Van Dongen, Jasper, Sleegers, Kristel, Thal, Dietmar Rudolf
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page n/a
container_issue S1
container_start_page
container_title Alzheimer's & dementia
container_volume 20
creator Gawor, Klara
Verrept, Sam
Laureyssen, Celeste
Tomé, Sandra O.
Vandenberghe, Rik
Vandenbulcke, Mathieu
Van Damme, Philip
von Arnim, Christina
Otto, Markus
Ghebremedhin, Estifanos
Ronisz, Alicja
Ospitalieri, Simona
Blaschko, Matthew
Van Dongen, Jasper
Sleegers, Kristel
Thal, Dietmar Rudolf
description Background Alzheimer’s disease (AD) brains commonly exhibit various co‐morbid pathologies, with cerebral amyloid angiopathy (CAA) being the most prevalent, affecting 70‐90% of patients. CAA can be restricted to medium and large vessels or extend to capillaries. Additionally, AD patients often show pathologies involving phosphorylated‐TDP‐43 (pTDP‐43) and alpha‐synuclein (αSyn), typically demonstrating an amygdala‐predominant subtype. The apolipoprotein E ε4 allele (APOE ε4) is a major genetic risk factor for Amyloid Beta (Aβ) pathology, but uncertainties remain regarding its impact on phosphorylated‐tau (pTau) and pTDP‐43. Methods To address this knowledge gap, we conducted a neuropathological examination of 237 brains, including 89 AD patients. We assessed pTau stages, Aβ phases, capillary involvement in CAA, and the presence of pTDP‐43 in the hippocampus. We also examined αSyn in the medulla oblongata, identifying the amygdala‐predominant variant using additional staining. APOE genotyping was performed on all individuals from frozen or paraffin‐embedded brain tissue. Results Our structural‐equation model revealed interrelationships among AD‐related neuropathologies, APOE, and age. We confirmed previous findings on substantial influence of the APOE ε4 allele on Aβ levels. We also identified an equally robust effect on capillary CAA, even after adjusting for the impact of Aβ on this pathology. Amygdala‐predominant αSyn was also affected by the presence of an APOE ε4 allele. Significant associations were observed between pTau and all measured pathologies. Importantly, after accounting for interactions, APOE ε4 showed no effect on pTau and pTDP‐43. Conclusions Our study suggests that APOE ε4 primary influence on pathological Tau is likely mediated through associations with Aβ, capillary CAA, and amygdala‐predominant αSyn. Similar conclusions might hold for APOE ε4 and p‐TDP‐43, although further confirmation with a larger sample size is needed. Despite indications from animal models, our results suggest that the impact of APOE ε4 on pTau in the human brain may be minimal, linked to its high interconnection with other brain pathologies.
doi_str_mv 10.1002/alz.086811
format article
fullrecord <record><control><sourceid>wiley_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11710043</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ALZ086811</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1691-f3bd2f1bee71e74dd6c660276870bf897022d94be2d6eb9902cbb42259c2983f3</originalsourceid><addsrcrecordid>eNp9kMtKw0AUhoMoWKsbn2DWQurM5L6SUOoFCnWhGzfDTOakGUlmQiZpSVd9BLe-Xp_EaKTgxtU5cL7_h_M5zjXBM4IxveXlbobjMCbkxJmQIKBuQKPk9LiH-Ny5sPYdYx_HJJg4u7nRGrJWGY0EtFsAjdLn1cJHXEvU8g4piyqQircg0UZxxKu-NEoe9h8Dz3-wtNwVoCpoDvtPizIz3GreFqY0awUWKY2KruIa8a41te2RaLjS9tI5y3lp4ep3Tp3X-8XL_NFdrh6e5unSzUiYEDf3hKQ5EQARgciXMszCENMojCMs8jiJMKUy8QVQGYJIEkwzIXxKgySjSezl3tS5G3vrTgyfZKDbhpesblTFm54Zrtjfi1YFW5sNIyQapPre0HAzNmSNsbaB_BgmmH17Z4N3NnofYDLCW1VC_w_J0uXbb-YLB5WK9A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Connection between APOE4 and tau is mediated via amyloid‐beta and Alzheimer’s co‐pathologies in human autopsy brains</title><source>Wiley-Blackwell Open Access Collection</source><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Gawor, Klara ; Verrept, Sam ; Laureyssen, Celeste ; Tomé, Sandra O. ; Vandenberghe, Rik ; Vandenbulcke, Mathieu ; Van Damme, Philip ; von Arnim, Christina ; Otto, Markus ; Ghebremedhin, Estifanos ; Ronisz, Alicja ; Ospitalieri, Simona ; Blaschko, Matthew ; Van Dongen, Jasper ; Sleegers, Kristel ; Thal, Dietmar Rudolf</creator><creatorcontrib>Gawor, Klara ; Verrept, Sam ; Laureyssen, Celeste ; Tomé, Sandra O. ; Vandenberghe, Rik ; Vandenbulcke, Mathieu ; Van Damme, Philip ; von Arnim, Christina ; Otto, Markus ; Ghebremedhin, Estifanos ; Ronisz, Alicja ; Ospitalieri, Simona ; Blaschko, Matthew ; Van Dongen, Jasper ; Sleegers, Kristel ; Thal, Dietmar Rudolf</creatorcontrib><description>Background Alzheimer’s disease (AD) brains commonly exhibit various co‐morbid pathologies, with cerebral amyloid angiopathy (CAA) being the most prevalent, affecting 70‐90% of patients. CAA can be restricted to medium and large vessels or extend to capillaries. Additionally, AD patients often show pathologies involving phosphorylated‐TDP‐43 (pTDP‐43) and alpha‐synuclein (αSyn), typically demonstrating an amygdala‐predominant subtype. The apolipoprotein E ε4 allele (APOE ε4) is a major genetic risk factor for Amyloid Beta (Aβ) pathology, but uncertainties remain regarding its impact on phosphorylated‐tau (pTau) and pTDP‐43. Methods To address this knowledge gap, we conducted a neuropathological examination of 237 brains, including 89 AD patients. We assessed pTau stages, Aβ phases, capillary involvement in CAA, and the presence of pTDP‐43 in the hippocampus. We also examined αSyn in the medulla oblongata, identifying the amygdala‐predominant variant using additional staining. APOE genotyping was performed on all individuals from frozen or paraffin‐embedded brain tissue. Results Our structural‐equation model revealed interrelationships among AD‐related neuropathologies, APOE, and age. We confirmed previous findings on substantial influence of the APOE ε4 allele on Aβ levels. We also identified an equally robust effect on capillary CAA, even after adjusting for the impact of Aβ on this pathology. Amygdala‐predominant αSyn was also affected by the presence of an APOE ε4 allele. Significant associations were observed between pTau and all measured pathologies. Importantly, after accounting for interactions, APOE ε4 showed no effect on pTau and pTDP‐43. Conclusions Our study suggests that APOE ε4 primary influence on pathological Tau is likely mediated through associations with Aβ, capillary CAA, and amygdala‐predominant αSyn. Similar conclusions might hold for APOE ε4 and p‐TDP‐43, although further confirmation with a larger sample size is needed. Despite indications from animal models, our results suggest that the impact of APOE ε4 on pTau in the human brain may be minimal, linked to its high interconnection with other brain pathologies.</description><identifier>ISSN: 1552-5260</identifier><identifier>EISSN: 1552-5279</identifier><identifier>DOI: 10.1002/alz.086811</identifier><language>eng</language><publisher>Hoboken: John Wiley and Sons Inc</publisher><subject>Basic Science and Pathogenesis</subject><ispartof>Alzheimer's &amp; dementia, 2024-12, Vol.20 (S1), p.n/a</ispartof><rights>2024 The Alzheimer's Association. published by Wiley Periodicals LLC on behalf of Alzheimer's Association.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11710043/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11710043/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,11541,27901,27902,46027,46451,53766,53768</link.rule.ids></links><search><creatorcontrib>Gawor, Klara</creatorcontrib><creatorcontrib>Verrept, Sam</creatorcontrib><creatorcontrib>Laureyssen, Celeste</creatorcontrib><creatorcontrib>Tomé, Sandra O.</creatorcontrib><creatorcontrib>Vandenberghe, Rik</creatorcontrib><creatorcontrib>Vandenbulcke, Mathieu</creatorcontrib><creatorcontrib>Van Damme, Philip</creatorcontrib><creatorcontrib>von Arnim, Christina</creatorcontrib><creatorcontrib>Otto, Markus</creatorcontrib><creatorcontrib>Ghebremedhin, Estifanos</creatorcontrib><creatorcontrib>Ronisz, Alicja</creatorcontrib><creatorcontrib>Ospitalieri, Simona</creatorcontrib><creatorcontrib>Blaschko, Matthew</creatorcontrib><creatorcontrib>Van Dongen, Jasper</creatorcontrib><creatorcontrib>Sleegers, Kristel</creatorcontrib><creatorcontrib>Thal, Dietmar Rudolf</creatorcontrib><title>Connection between APOE4 and tau is mediated via amyloid‐beta and Alzheimer’s co‐pathologies in human autopsy brains</title><title>Alzheimer's &amp; dementia</title><description>Background Alzheimer’s disease (AD) brains commonly exhibit various co‐morbid pathologies, with cerebral amyloid angiopathy (CAA) being the most prevalent, affecting 70‐90% of patients. CAA can be restricted to medium and large vessels or extend to capillaries. Additionally, AD patients often show pathologies involving phosphorylated‐TDP‐43 (pTDP‐43) and alpha‐synuclein (αSyn), typically demonstrating an amygdala‐predominant subtype. The apolipoprotein E ε4 allele (APOE ε4) is a major genetic risk factor for Amyloid Beta (Aβ) pathology, but uncertainties remain regarding its impact on phosphorylated‐tau (pTau) and pTDP‐43. Methods To address this knowledge gap, we conducted a neuropathological examination of 237 brains, including 89 AD patients. We assessed pTau stages, Aβ phases, capillary involvement in CAA, and the presence of pTDP‐43 in the hippocampus. We also examined αSyn in the medulla oblongata, identifying the amygdala‐predominant variant using additional staining. APOE genotyping was performed on all individuals from frozen or paraffin‐embedded brain tissue. Results Our structural‐equation model revealed interrelationships among AD‐related neuropathologies, APOE, and age. We confirmed previous findings on substantial influence of the APOE ε4 allele on Aβ levels. We also identified an equally robust effect on capillary CAA, even after adjusting for the impact of Aβ on this pathology. Amygdala‐predominant αSyn was also affected by the presence of an APOE ε4 allele. Significant associations were observed between pTau and all measured pathologies. Importantly, after accounting for interactions, APOE ε4 showed no effect on pTau and pTDP‐43. Conclusions Our study suggests that APOE ε4 primary influence on pathological Tau is likely mediated through associations with Aβ, capillary CAA, and amygdala‐predominant αSyn. Similar conclusions might hold for APOE ε4 and p‐TDP‐43, although further confirmation with a larger sample size is needed. Despite indications from animal models, our results suggest that the impact of APOE ε4 on pTau in the human brain may be minimal, linked to its high interconnection with other brain pathologies.</description><subject>Basic Science and Pathogenesis</subject><issn>1552-5260</issn><issn>1552-5279</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><recordid>eNp9kMtKw0AUhoMoWKsbn2DWQurM5L6SUOoFCnWhGzfDTOakGUlmQiZpSVd9BLe-Xp_EaKTgxtU5cL7_h_M5zjXBM4IxveXlbobjMCbkxJmQIKBuQKPk9LiH-Ny5sPYdYx_HJJg4u7nRGrJWGY0EtFsAjdLn1cJHXEvU8g4piyqQircg0UZxxKu-NEoe9h8Dz3-wtNwVoCpoDvtPizIz3GreFqY0awUWKY2KruIa8a41te2RaLjS9tI5y3lp4ep3Tp3X-8XL_NFdrh6e5unSzUiYEDf3hKQ5EQARgciXMszCENMojCMs8jiJMKUy8QVQGYJIEkwzIXxKgySjSezl3tS5G3vrTgyfZKDbhpesblTFm54Zrtjfi1YFW5sNIyQapPre0HAzNmSNsbaB_BgmmH17Z4N3NnofYDLCW1VC_w_J0uXbb-YLB5WK9A</recordid><startdate>202412</startdate><enddate>202412</enddate><creator>Gawor, Klara</creator><creator>Verrept, Sam</creator><creator>Laureyssen, Celeste</creator><creator>Tomé, Sandra O.</creator><creator>Vandenberghe, Rik</creator><creator>Vandenbulcke, Mathieu</creator><creator>Van Damme, Philip</creator><creator>von Arnim, Christina</creator><creator>Otto, Markus</creator><creator>Ghebremedhin, Estifanos</creator><creator>Ronisz, Alicja</creator><creator>Ospitalieri, Simona</creator><creator>Blaschko, Matthew</creator><creator>Van Dongen, Jasper</creator><creator>Sleegers, Kristel</creator><creator>Thal, Dietmar Rudolf</creator><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>202412</creationdate><title>Connection between APOE4 and tau is mediated via amyloid‐beta and Alzheimer’s co‐pathologies in human autopsy brains</title><author>Gawor, Klara ; Verrept, Sam ; Laureyssen, Celeste ; Tomé, Sandra O. ; Vandenberghe, Rik ; Vandenbulcke, Mathieu ; Van Damme, Philip ; von Arnim, Christina ; Otto, Markus ; Ghebremedhin, Estifanos ; Ronisz, Alicja ; Ospitalieri, Simona ; Blaschko, Matthew ; Van Dongen, Jasper ; Sleegers, Kristel ; Thal, Dietmar Rudolf</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1691-f3bd2f1bee71e74dd6c660276870bf897022d94be2d6eb9902cbb42259c2983f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Basic Science and Pathogenesis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gawor, Klara</creatorcontrib><creatorcontrib>Verrept, Sam</creatorcontrib><creatorcontrib>Laureyssen, Celeste</creatorcontrib><creatorcontrib>Tomé, Sandra O.</creatorcontrib><creatorcontrib>Vandenberghe, Rik</creatorcontrib><creatorcontrib>Vandenbulcke, Mathieu</creatorcontrib><creatorcontrib>Van Damme, Philip</creatorcontrib><creatorcontrib>von Arnim, Christina</creatorcontrib><creatorcontrib>Otto, Markus</creatorcontrib><creatorcontrib>Ghebremedhin, Estifanos</creatorcontrib><creatorcontrib>Ronisz, Alicja</creatorcontrib><creatorcontrib>Ospitalieri, Simona</creatorcontrib><creatorcontrib>Blaschko, Matthew</creatorcontrib><creatorcontrib>Van Dongen, Jasper</creatorcontrib><creatorcontrib>Sleegers, Kristel</creatorcontrib><creatorcontrib>Thal, Dietmar Rudolf</creatorcontrib><collection>Wiley-Blackwell Open Access Collection</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Alzheimer's &amp; dementia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gawor, Klara</au><au>Verrept, Sam</au><au>Laureyssen, Celeste</au><au>Tomé, Sandra O.</au><au>Vandenberghe, Rik</au><au>Vandenbulcke, Mathieu</au><au>Van Damme, Philip</au><au>von Arnim, Christina</au><au>Otto, Markus</au><au>Ghebremedhin, Estifanos</au><au>Ronisz, Alicja</au><au>Ospitalieri, Simona</au><au>Blaschko, Matthew</au><au>Van Dongen, Jasper</au><au>Sleegers, Kristel</au><au>Thal, Dietmar Rudolf</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Connection between APOE4 and tau is mediated via amyloid‐beta and Alzheimer’s co‐pathologies in human autopsy brains</atitle><jtitle>Alzheimer's &amp; dementia</jtitle><date>2024-12</date><risdate>2024</risdate><volume>20</volume><issue>S1</issue><epage>n/a</epage><issn>1552-5260</issn><eissn>1552-5279</eissn><abstract>Background Alzheimer’s disease (AD) brains commonly exhibit various co‐morbid pathologies, with cerebral amyloid angiopathy (CAA) being the most prevalent, affecting 70‐90% of patients. CAA can be restricted to medium and large vessels or extend to capillaries. Additionally, AD patients often show pathologies involving phosphorylated‐TDP‐43 (pTDP‐43) and alpha‐synuclein (αSyn), typically demonstrating an amygdala‐predominant subtype. The apolipoprotein E ε4 allele (APOE ε4) is a major genetic risk factor for Amyloid Beta (Aβ) pathology, but uncertainties remain regarding its impact on phosphorylated‐tau (pTau) and pTDP‐43. Methods To address this knowledge gap, we conducted a neuropathological examination of 237 brains, including 89 AD patients. We assessed pTau stages, Aβ phases, capillary involvement in CAA, and the presence of pTDP‐43 in the hippocampus. We also examined αSyn in the medulla oblongata, identifying the amygdala‐predominant variant using additional staining. APOE genotyping was performed on all individuals from frozen or paraffin‐embedded brain tissue. Results Our structural‐equation model revealed interrelationships among AD‐related neuropathologies, APOE, and age. We confirmed previous findings on substantial influence of the APOE ε4 allele on Aβ levels. We also identified an equally robust effect on capillary CAA, even after adjusting for the impact of Aβ on this pathology. Amygdala‐predominant αSyn was also affected by the presence of an APOE ε4 allele. Significant associations were observed between pTau and all measured pathologies. Importantly, after accounting for interactions, APOE ε4 showed no effect on pTau and pTDP‐43. Conclusions Our study suggests that APOE ε4 primary influence on pathological Tau is likely mediated through associations with Aβ, capillary CAA, and amygdala‐predominant αSyn. Similar conclusions might hold for APOE ε4 and p‐TDP‐43, although further confirmation with a larger sample size is needed. Despite indications from animal models, our results suggest that the impact of APOE ε4 on pTau in the human brain may be minimal, linked to its high interconnection with other brain pathologies.</abstract><cop>Hoboken</cop><pub>John Wiley and Sons Inc</pub><doi>10.1002/alz.086811</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1552-5260
ispartof Alzheimer's & dementia, 2024-12, Vol.20 (S1), p.n/a
issn 1552-5260
1552-5279
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11710043
source Wiley-Blackwell Open Access Collection; Publicly Available Content Database; PubMed Central
subjects Basic Science and Pathogenesis
title Connection between APOE4 and tau is mediated via amyloid‐beta and Alzheimer’s co‐pathologies in human autopsy brains
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-22T23%3A17%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Connection%20between%20APOE4%20and%20tau%20is%20mediated%20via%20amyloid%E2%80%90beta%20and%20Alzheimer%E2%80%99s%20co%E2%80%90pathologies%20in%20human%20autopsy%20brains&rft.jtitle=Alzheimer's%20&%20dementia&rft.au=Gawor,%20Klara&rft.date=2024-12&rft.volume=20&rft.issue=S1&rft.epage=n/a&rft.issn=1552-5260&rft.eissn=1552-5279&rft_id=info:doi/10.1002/alz.086811&rft_dat=%3Cwiley_pubme%3EALZ086811%3C/wiley_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1691-f3bd2f1bee71e74dd6c660276870bf897022d94be2d6eb9902cbb42259c2983f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true